Sutro Biopharma, Inc. Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Deficit) (Tables)

3 Months Ended

Mar. 31, 2019

The Company had reserved common stock, on an if-converted basis, for issuance as follows:

	March 31, 2019		December 31, 2018
Common stock options issued and outstanding		3,874,914		3,111,718
Common stock awards issued and outstanding		464,900		311,240
Remaining shares reserved for issuance under 2004 and 2018 Equity Incentive Plan		2,742,059		2,525,610
Shares reserved for issuance under 2018 Employee Stock Purchase Plan		389,571		230,000
Warrants to purchase common stock		71,813		71,813
Total		7,543,257		6,250,381